書籍詳細

第1章 絨毛性疾患の特徴

P.6 掲載の参考文献

• 1) 日本産科婦人科学会・日本病理学会編:絨毛性疾患取り扱い規約. p8-19, 金原出版, 東京, 1995.

• 2) 石塚直隆ほか:絨毛癌と侵入奇胎の臨床診断に関する 「絨毛癌診断スコア」 の検討. 日産婦誌 36:459-462, 1984.

• 3) Scully RE, et al:Histological Typing of Female Genital Tract Tumours. 2nd ed. p31-38, Gestational trophoblastic disease. WHO, 1994.

• 4) Ishizuka N:Studies on trophoblastic neoplasia. In:Gann Monograph on, Cancer Research, No. 18, Cancer in Asia. p203-216, Edited by Hirayama T, University of Tokyo Press, 1976.

• 5) Hara T, Kaseki S, Tomoda Y, et al:Determinants of risk for developing invasive mole and choriocarcinoma following hydatidiform mole. Asia-Oceania J Obstet Gynecol 12 (2):241-250, 1986.

• 6) Registration Committee for Trophoblastic Disease of the Japan Society of Obstetrics and Gynecology:Report of the Registration Committee for Trophoblastic Disease. Acta Obst Gynaec Jpn 39:871-880, 1987.

• 7) Bagshawe KD, Dent J:Hydatidiform mole in England and Wales 1973-83. The Lancet 2:673-677, 1986.

第2章 胞状奇胎妊娠

P.17 掲載の参考文献

• 1) 日本産科婦人科学会・日本病理学会編:絨毛性疾患取り扱い規約. p8-19, 金原出版, 東京, 1995.

• 2) Kajii T, Ohama K:Androgenetic origin of hydatidiform mole. Nature 268:633, 1977.
  pubmed

• 3) Jacobs PA, Szulman AE, et al:Human Triploidy relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole. Amer. Hum. Genet 46:223, 1982.

• 4) Bandy LC, Clarke-Peason DL, Hammond CB:Malignant potential gestational trophoblastic disease at the extreme age of reproductive life. Obstet Gynecol 64:395-399, 1984.

• 5) Atrash HK, Hogue CJR, Grimes DA:Epidemiology of hydatidiform mole during early gestation. Am J Obst Gynecol 154:906-909, 1986.

• 6) Vassilakos P, Riotton G, Kajii T:Hydatidiform mole:Two entities. Am J Obst Gynecol 127:167-170, 1977.
  pubmed

• 7) Wake N, ShiinaY, Ichinoe K:A further cytogenetic study of hydatidiform mole, with reference to its androgenetic origin. Proc Japan Acad 54 (Ser B):533-537, 1978.

• 8) Wake N, Takagi N, Sasaki M:Androgenesis as a cause of hydatidiform mole. J Natl Cancer Inst 60:51-57, 1978.
  pubmed

• 9) Yamashita K, Wake N, Araki T, et al:Human lymphocyte antigen expression in hydatidiform mole; Androgenesis following fertilization by a haploid sperm. Am J Obst Gynecol 135:597-600, 1979.
  pubmed

• 10) Ringertz N:Hydatidiform mole, invasive mole and choriocarcinoma in Sweden 1958-1965. Acta Obstet Gynecol 49:195-203, 1970.
  pubmed

• 11) Ohama K, Kajii T, Okamoto E, et al:Dispermic origin of XY hydatidiform moles. Nature 292:551-552, 1981.
  pubmed

• 12) Berkowitz RS, Sandstrom M, Goldstein DP, et al:45, X Complete Hydatidiform mole. Gynecol Oncol 14:279-283, 1982
  pubmed

• 13) Wake N, Seki T, Fujiya H, et al:Malignant potential of homozygous and heterozygous complete moles. Cancer Res 44:1226-1230, 1984.

• 14) 上田克憲:部分胞状奇胎に関する細胞遺伝学的, 形態学的, ならびに臨床的研究. 日産婦誌 37:1071, 1985.

• 15) Surani MA, Barton SC and Norris ML:Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 308:548-550, 1984.
  pubmed

• 16) Hara T, Kaseki S, Tomoda Y, et al:Determinants of risk for developing invasive mole and choriocarcinoma following hydatidiform mole. Asia Oceania J Obstet Gynecol 12:241-250, 1986.

• 17) Goto S, Nishi H, Tomoda Y:Blood group Rh-D factor in human trophoblast determined by immunofluorescent method. Am J Obst Gynecol 137:707-712, 1980.

• 18) Tomoda Y, Kaseki S, Goto S, et al:Rh-D factor in trophoblastic tumors; A possible cause of the high incidence in Asia. Am J Obst Gynecol 139:742-743, 1981.
  pubmed

第3章 胞状奇胎娩出後の登録管理

P.34 掲載の参考文献

• 1) Goto S, Yamada A, et al:Development of post molar trophoblastic disease after partial molar pregnancy. Gynecol Oncol 48:165-170, 1993.

• 2) 婦人科腫瘍委員会報告:部分胞状奇胎の取り扱いに関する小委員会 (委員長:山辺 徹, 小委員長:友田 豊). 日産婦誌 46(3):285-288, 1994.

• 3) Bagshawe KD, Lawler SD, et al:Gestational trophoblastic tumors following initial diagnosis of partial hydatidiform mole. Lancet 335:1074, 1990.
  pubmed

• 4) Kashimura Y, Kashimura M, Sugimori H, et al:Prophylactic chemotherapy for hydatidiform mole. Cancer 58:624-629, 1986.
  pubmed

• 5) Bandy LC, Clarke-Peason DL, and Hammond CB:Malignant potential of gestational trophoblastic disease at the extreme age of reproductive life.Obstet Gynecol 64:395-399, 1984.

• 6) Tsukamoto N, Iwasaka T, Kashimura Y, et al:Gestational trophoblastic disease in women aged 500 or more. Gynecol Oncol 20:53-61, 1985.

• 7) Yuen BH and Callegari PB:Risk of post-molar invasive complications with oral contraceptive use. Am J Obst Gynecol 153:924-926, 1985.

• 8) Lurain JR, Brewer JI, Trok EE, et al:Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 145:591-595, 1983.

第4章 ヒト絨毛性性腺刺激ホルモン(hCG)

P.48 掲載の参考文献

• 1) Vaitukaitis JL, Braunstein GD, Ross GT:A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol 113:751-758, 1972.
  pubmed

• 2) Cole LA, Wang Y, et al:Urinary Human Chorionic Gonadotropin Free β-Subunit and β-Core Fragment:a New Marker of Gynecological Cancers. Cancer Res 48:1356-1360, 1988.

• 3) Birken S, Armstrong EG, et al:Structure of human chorionic gonadotropin β-subunit fragment from pregnancy urine. Endocrinol 123:572-583, 1988.

• 4) TomodaY, Hreshchyshyn MM:Radioimmunoassay for human chorionic gonadotropin. Am J Obstet & Gynec 100:118-121, 1968.
  pubmed

• 5) Suzuki N, Konishi E, Kondo K, et al:A highly sensitive colorimetric sandwich-enzyme immunoassay for human chorionic gonadotropin using specific antibodies against the carbonyl-terminal portion of the β-subunit. Clinica Chemica Acta 150:247-253, 1985.

• 6) Nishimura R, et al:Molecular Forms of Human Chorionic Gonadotropin in Choriocarcinoma Serum and Urine. Jpn J Cancer Res 80:968-974, 1989.
  pubmed

• 7) Chen Fan, et al:Radioimmunoassay of the Serum Free β-subunit of Human Chorionic Gonadotropin in Trophoblastic Disease. J Clin Endocrinol Metab 64:313-318, 1987.

• 8) Suginami H, et al:Immunohistochemical Localization of a Human Chorionic Gonadotropin-Like Substance in the Human Pituitary Gland. J Clin Endocrinol Metab 55:1161-1166, 1982.
  pubmed

• 9) Stockell Hartree A, et al:Studies of the human chorionic gonadotropin-like substance of human pituitary glands in its significance. J Endocrinol 96:115-126, 1983.

• 10) Matsuura S, et al:Physicochemical and immunological characterization of anHCG-like substance from human pituitary glands. Nature 14:740-741, 1984.

• 11) Fiddes JC, et al:Structure, expression, and evolution of the genes for the human glycoprotein hormones. Recent Prog Horm Res 40:43-74, 1984.
  pubmed

• 12) Hoermann RG, et al:Evidence for the Presence of Human Chorionic Gonadotropin and Free β-Subunit of hCG in the Human Pituitary. J Clin Endocrinol Metab 71:179-186, 1990.

• 13) Nakano R, et al:Effects of gonadotropin-releasing hormone and estrogen on serum levels of human chorionic Gonadotropin-like substance in post menopausalwomen. Fertil and Steril 54:161-163, 1990.

• 14) Su-Cheng Huang, et al:The Secretion of Human Chorionic Gonadotropin-Like Substance in Women Employing Contraceptive Measures. J Clin Endocrinol Metab 58:646-653, 1984.

• 15) Sugiura M, Goto S, Saito M, et al:The establishment and characterization of three new gestational choriocarcinoma cell lines. Acta Obst Gynaec Jpn 40:1447-1454, 1988.

• 16) 友田 豊ら:絨毛性疾患の管理. 産婦治療 61:395(629), 1990.

• 17) 友田 豊ら:難治性絨毛癌に対する集学的治療. 産婦人科MOOK 38:183, 1987.

第5章 絨毛性疾患の画像診断

P.68 掲載の参考文献

• 1) Hussain S and Ansari A:Ultrasound patterns of trophoblastic disease. Clin Radiol 33:593, 1982.
  pubmed

• 2) Munyer TP, Callen PW, Filly RA, et al:Further observasion on the sonographic spectrum of gestational trophoblastic disease. J Clin Ultrasound 9:349, 1981.

• 3) 友田 豊, 山本 真一, 石塚 隆夫:がんの画像診断図譜-16. 絨毛性疾患. 綜合臨牀 36(増刊):268-282, 1987.

• 4) Borell U, Fernstrom I, Westman A:The value of pelvic arteriography in the diagnosis of mole and choriocarcinoma. Acta Radiologica 44:378-384, 1955.
  pubmed

• 5) Itoh G:Diagnostic significance of pelvic angiography in trophoblastic neoplasia. Acta Obst Gynaec Jpn 20:1361-1369, 1968 (in Japanese).

• 6) Ishizuka N:Studies on trophoblastic neoplasia. In:Gann Monograph on Cancer Research. Vol 18, Cancer in Asia. p203-216, Editied by Hirayama T, University of Tokyo Press, Tokyo, 1976.

• 7) Tsai WS:Use of sonar in diagnosis and management of invasive gestational trophoblastic tumors. Int J Fertil 19:227-232, 1974

• 8) Levin DC, Staiano S, Schneider M, et al:Complementary role of sonography and arteriography in management of uterine choriocarcinoma. Am J Roentgenol Radium Ther Nucl Med 125:462-468, 1975.
  pubmed

• 9) Kobayashi M:Use of diagnostic ultrasound in trophoblastic neoplasma and ovarian tumors. Cancer 38:441-452, 1976.

• 10) Yamamoto S, Ishizuka T, Kaseki S, et al:Evaluation of ultrasonography in management of choriocarcinoma and invasive mole. Acta Obstet Gynaec Jpn 39:2165-2172, 1987 (in Japanese).

• 11) Long MG, Boultbee JE, Langley R, et al:Doppler assessment of the uterine circulation and the clinical behaviour of gestational trophoblastic tumours requiring chemotherapy. Br J Cancer 66:883-887, 1992.
  pubmed

• 12) Carter J, Fowler J, Carlson J, et al:Transvaginal Color Flow Doppler Sonography in the Assessment of Gestational Trophoblastic Disease. J Ultrasound Med 12:595-599, 1993.
  pubmed

• 13) Mangili G, Spagnolo D, Valsecchi L, et al:Transvaginal ultrasonography in persistent trophoblastic tumor. Am J Obstet Gynecol 169:1218-1223, 1993.
  pubmed

• 14) Hsieh F-J, Wu C-C, Lee C-N, et al:Vascular Patterns of Gestational Trophoblastic Tumors by Color Doppler Ultrasound. Cancer 74:2361-2365, 1994.
  pubmed

• 15) Ishizuka N, Kaseki S:Gynecological disease and chest X-ray appearance. Obstet Gynecol 45:745-751, 1970 (in Japanese).

• 16) Tomoda Y, Arii Y, Kaseki S, et al:Surgical indications for resection in pulmonary metastasis of choriocarcinoma. Cancer 46:2723-2730, 1980.
  pubmed

• 17) 木田義久, 小林達也, 吉田 純ほか:絨毛癌の脳転移-神経放射線学的診断法について-. CT研究 3(2):175-180, 1981.

• 18) Ishizuka T, Tomoda Y, Kaseki S, et al:Intracranial metastasis of choriocarcinoma-A Clinicopathologic Study. Cancer 52:1896-1903, 1983.
  pubmed

第6章 侵入奇胎と絨毛癌の鑑別診断

P.81 掲載の参考文献

• 1) Marchand F:Uber die sogenannten "decidualen" Geschwulste im Anschluss an normale Geburt, Abort, Blasenmole und Extrauterinschwangerschaft. Monatsschrift fur Geburt-shulfe und Gynaekologie 1:419-438, 1895.

• 2) Novak E Baltimore:Pathological aspects of hydatidiform mole and choriocarcinoma. Am J Obst Gynecol 56:1355-1372, 1950.

• 3) Novak E Baltimore, Seah CS:Choriocarcinoma of the uterus-Study of 74 cases from the Mathieu Memorial Chorionepithelioma Registry. Am J Obst Gynec 67:933-961, 1954.

• 4) Hertz R:Eight years experience with the chemotherapy of Choriocarcinoma and related trophoblastic tumors. Choriocarcinoma, UICC Monograph Series 3:66-71, 1967.

• 5) Ishizuka N:Chemotherapy for chorionepithelioma. Gann 47:460-462, 1956.
  pubmed

• 6) Ishizuka N:Chemotherapy of Chorionic Tumors. Choriocarcinoma, UICC Monograph Series 3:116-118, 1967.

• 7) 日本産科婦人科学会・日本病理学会編:絨毛性疾患取り扱い規約. p8-19, 金原出版, 東京, 1995.

• 8) 大口善市:絨毛上皮腫および破壊性胞状奇胎120例の臨床的研究-ことに両者の性格の相違について-. 日産婦誌, 18(9):1083, 1966.

• 9) Ishizuka N:Studies on trophoblastic neoplasia. Gann Monograph on Cancer Research. No. 18, Cancer in Asia. p203-216, Edited by Hirayama T, Universityof Tokyo Press, Tokyo, 1976.

• 10) Ishizuka N, TomodaY, Kaseki S, et al:Assessment of "choriocarcinoma risk score table" for clinical differentiation between choriocarcinoma and invasive mole. Acta Obst Gynecol Jpn 36:459-462, 1984 (in Japanese).

• 11) Lurain JR, Brewer JI, Trok EE, et al:Gestational trophoblastic disease; Treatment results at the Brewer trophoblastic disease center. Obstet Gynecol 60:354-360, 1982.

• 12) Hammond CB, Borchert LG, TyreyL, et al:Treatment of metastatic trophoblastic disease; Good and poor prognosis. Am J Obstet Gynecol 115:451-457, 1973.
  pubmed

• 13) Bagshawe KD:Risk and prognostic factor in trophoblastic neoplasia. Cancer 38:1373-1385, 1976.
  pubmed

• 14) Goldstein DP:Worldwide controversies in gestational trophoblastic neoplasms. J Gynaecol Obstet 15:207-215, 1977.
  pubmed

第7章 侵入奇胎の治療と予後

P.94 掲載の参考文献

• 1) Lurain JR, Brewer J:Invasive Mole. Seminars in Oncology 9:174-180, 1982.
  pubmed

• 2) Bardawil WA, Hertig AT, Velardo JT:Regression of trophoblast. Hydatidiform mole; a case of unusual features, possibly metastasis and regression; review of literature. Obstet Gynecol 10:614-625, 1957.
  pubmed

• 3) Hertz R, Ross GT, Lipsett MB:Primary chemotherapy of nonmetastatic trophoblastic disease in women. Am J Obstet Gynecol 86:808-814, 1963.
  pubmed

• 4) Hammond CB, Borchert LG, Tyrey L, et al:Treatment of metastatic trophoblastic disease; Good and poor prognosis. Am J Obstet Gynecol 115:451-457, 1973.
  pubmed

• 5) Goldstein DP:The chemotherapy of gestational trophoblastic disease. JAMA 220:209-213, 1972.
  pubmed

• 6) Kaseki S:Primary chemotherapy of trophoblastic neoplasia-Experience with 123 cases. Acta Obstet Gynecol 26:1069-1076, 1974.

• 7) Hirokawa K, Tomoda Y, Kaseki S, et al:Recurrence of invasive moles and choriocarcinomas. Asia Oceania J Obstet Gynecol 12:11-20, 1986.

• 8) Bagshawe KD:Choriocarcinoma. p61, Edward Arnold Ltd, London, 1969.

• 9) Report by the Registration Committee for Trophoblastic Disease. Acta Obstet Gynecol Jap 39:871-880, 1987.

第8章 絨毛癌の臨床病態

P.113 掲載の参考文献

• 1) Suzuki T, Goto S, Nawa A, et al:Identification of the pregnancy responsible for gestational trophoblastic disease by DNA analysis. Obstet Gynecol 82 (4):629-634, 1993.
  pubmed

• 2) 友田 豊, 有井吉太郎, 可世木成明ほか:絨毛性腫瘍の追跡検査法(BBTも含めて). 産と婦 45(4):157-164, 1978.

• 3) Nishikawa Y, Kaseki S, Tomoda Y, et al:Histopathologic classification of uterine choriocarcinoma. Cancer 55:1044-1051, 1985.
  pubmed

• 4) 鈴木寿雄, 可世木成明, 有井吉太郎ほか:絨毛癌の予後因子の分析. 日産婦誌 31(12):2220-2228, 1979.

• 5) Bagshawe KD:Metastatic choriocarcinoma. Choriocarcinoma, p93, Edward Arnold Ltd, London, 1969.

• 6) Ishizuka T, Tomoda Y, Kaseki S, et al:Intracranial metastasis of choriocarcinoma-A clinicopathologic study.Cancer 52:1896-1903, 1983.
  pubmed

• 7) Posner JB:Management of central nervous system metastasis. Seminars in Oncology 4:81-91, 1977.
  pubmed

• 8) Hertz R:Eight years experience with the chemotherapy of Choriocarcinoma and related trophoblastic tumors., Choriocarcinoma. UICC Monograph Series 3:66-71, 1967.

• 9) Hammond CB, Borchert LG, Tyrey L, et al:Treatment of trophoblastic disease-Good and poor prognosis. Am J Obstet Gynecol 115:451-457, 1973.
  pubmed

• 10) Bagshawe KD:Risk and prognostic factors in trophoblastic neoplasia. Cancer 38:1373-1385, 1976.
  pubmed

• 11) Takeuchi S, Kanazawa K, Ichinohe K, et al:Phase 2 study of Etoposide (NK171) in trophoblastic disease. J Jpn Soc Cancer Ther 21:1266-1276, 1986 (in Japanese).

• 12) Novak E Baltimore, Seah CS:Choriocarcinoma of the uterus; Study of 74 cases from the Mathieu Memorial Chorionepithelioma Registry. Am J Obst Gynec 67:933-961, 1954.

• 13) Ishizuka N:Studies on trophoblastic neoplasia. Gann Monograph on Cancer Research. No.18, Cancer in Asia. p203-216, Edited by Hirayama T, Universityof Tokyo Press, Tokyo, 1976.

• 14) Kurman RJ, Scully RE, Norris HJ:Trophoblastic pseudotumor of the uterus; An exaggerated form of "syncytial endometritis" simulating a malignant tumor. Cancer 38:1214-1226, 1976.
  pubmed

• 15) Scully RE, Young RH:Trophoblastic pseudotumor; A reappraisal.Am J Surg Pathol 5:75-76, 1981.
  pubmed

• 16) 日本産科婦人科学会・日本病理学会編:絨毛性疾患取り扱い規約. p8-19, 金原出版, 東京, 1995.

• 17) 並木恒夫:胎盤の病理(4). 病理と臨床8 (7):931-935, 1990.

第9章 絨毛癌患者の化学療法

P.133 掲載の参考文献

• 1) Ishizuka N:Chemotherapy for choriocarcinoma. Gann 47:460-462, 1956.
  pubmed

• 2) Ishizuka N:Chemotherapy of chorionic tumors. Choriocarcinoma. UICC Monograph Series 3:116-118, 1967.

• 3) Ishizuka N:Studies on trophoblastic neoplasia. Gann Monograph on Cancer Research. No.18, Cancer in Asia. p203-216, Edited by Hirayama T, Universityof Tokyo Press, Tokyo, 1976.

• 4) Li MC, Hertz R, Spencer DB:Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med 93:361-366, 1956.
  pubmed

• 5) Hertz R, Bergenstal DM, Lipsett MB, et al:Chemotherapy of choriocarcinoma and related trophoblastic tumors in women. JAMA 168:845-854, 1958.

• 6) Ross GT, Stolbach LL, Hertz R:Actinomycin D in the treatment of methotrexate resistant trophoblastic disease in women. Cancer Res 22:1015-1017, 1962.
  pubmed

• 7) Hertz R:Eight years experience with the chemotherapy of choriocarcinoma and related trophoblastic tumors in women. Choriocarcinoma, UICC Monograph Series 3:66-71, 1967.

• 8) Li MH, Whitmore WF, Golbey R, et al:Effects of combined drug therapy on metastatic cancer of the testis. JAMA 174:1291-1299, 1960.

• 9) Stilp TJ, Bucy PC, Brewer JI:Cure of metastatic choriocarcinoma of the brain. JAMA 221:276-279, 1972.
  pubmed

• 10) Hammond CB, Borchert LG, Tyrey L, et al:Treatment of metastatic trophoblastic disease; Good and poor prognosis. Am J Obstet Gynecol 115:451-457, 1973.
  pubmed

• 11) Kawai N, Hreshchyshyn MM:The effect of methotrexate and dactinomycin on transplantable malignant and benign trophoblastic growths. Am J Obstet Gynecol 107:513-518, 1970.
  pubmed

• 12) Takeuchi S, Kanazawa K, Ichinohe K, et al:Phase 2 study of Etoposide (NK171) in trophoblastic disease. J Jpn Soc Cancer Ther 21:1266-1276, 1986 (in Japanese).

• 13) 中西 透, 加藤紀子, 鈴木孝信ほか:絨毛性疾患の化学療法による好中球減少に対する Recombinant Human Granulocyte Colony-Stimulating Factor (rG-CSF) の臨床効果. BIOTHERAPY 7:167-171, 1993.

• 14) Bagshawe KD:Treatment of trophoblastic tumors. Cancer Res 62:192-199, 1977.
  pubmed

• 15) Surwit EA, Suciu TN, Schmidt HJ, et al:A new combination chemotherapy for resistant trophoblastic disease. Gynecol Oncol 8:110-118, 1979.
  pubmed

• 16) Hainsworth JD, Burnett LS, Jones HW, et al:Resistant gestational choriocarcinoma; Successful treatment with vinblastine, bleomycin, and cisplatin. Cancer Treatment Reports 67:393-395, 1983.
  pubmed

• 17) Newlands ES:New chemotherapeutic agents in the management of gestational choriocarcinoma. Seminars in Oncology 9:239-243, 1982.
  pubmed

• 18) Yamamoto T, Shiroshita K, Tsuji M, et al:Treatment of drug-tolerant, choriocarcinoma in combination with bleomycin, cisplatin and VP16-213. Asia-Oceania J Obstet Gynecol 12:237-240, 1986.

• 19) Wong LC, Choo YC, Ma HK:Etoposide, methotrexate, and bleomycin in drug-resistant gestational trophoblastic disease. Gynecol Oncol 24:51-57, 1986.
  pubmed

• 20) Bagshawe KD:Chemotherapy and general treatment-current and future developments. Gynecologic Oncology, Surgery and Urology, 243-249, 1987.

• 21) Hammond CB, Weed JC, Currie JL:The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol 136:844-858, 1980.
  pubmed

第10章 絨毛癌の手術療法と放射線療法

P.147 掲載の参考文献

• 1) Tomoda Y, Arii Y, Kaseki S, et al:Surgical indications for resection in pulmonary metastasis of choriocarcinoma. Cancer 46:2723-2730, 1980.
  pubmed

• 2) Thomford NR, Woolner LB, Clagett OT:The surgical treatment of metastic tumors in the lungs. J Thoracic Cardiovasc Surg 49:357-363, 1965.

• 3) Lurain JR, Brewer I, Torok EE, et al:Gestational trophoblastic disease; Treatment results at the Brewer Trophoblastic Disease Center. Obstet Gynecol 60:354-360, 1982.

• 4) 木田義久, 小林達也, 吉田 純ほか:絨毛癌の脳転移-神経放射線学的診断法について-. CT研究 3(2):175-180, 1981.

• 5) Ishizuka T, Tomoda Y, Kaseki S, et al:Intracranial metastasis of choriocarcinoma-A Clinicopathologic Study. Cancer 52:1896-1903, 1983.
  pubmed

• 6) 友田 豊, 可世木成明, 石塚隆夫ほか:絨毛癌脳転移に対する手術療法の評価. 日産婦誌 32(11):1792-1800, 1980.

• 7) Weed JC, Hammond CB:Cerebral metastasis of choriocarcinoma; Intensive therapy and prognosis. Obstet Gynecol 58:89-94, 1980.

• 8) Athanassiou A, Begent RHJ, Newlands ES, et al:Central nervous system metastasis of choriocarcinoma-23 years' experience at Charing Cross Hospital. Cancer 52:1728-1735, 1983.

• 9) Wolf AL, Adcock LL, Hachiya JT, et al:Choriocarcinoma with brain metastasis-Successful management of increased intracranial pressure with Barbiturates. Cancer 52:1896-1903, 1983.

• 10) Brace KC:The role of irradiation in the treatment of metastatic trophoblastic disease. Radiology 91:540-544, 1968.

第11章 絨毛癌の再発症例と死亡症例の分析

P.159 掲載の参考文献

• 1) Tomoda Y, Asai Y, Arii Y, et al:Criteria of complete remission from trophoblastic neoplasia with the use of human chorionic gonadotropin excretion pattern as a parameter. Cancer 40:1016-1025, 1977.
  pubmed

• 2) Hirokawa K, Tomoda Y, Kaseki S, et al:Recurrence of invasive moles and choriocarcinoma. Asia-Oceania J Obstet Gynecol 12:11-20, 1986.

• 3) Katoh S, Hattori S, Furuhashi Y, et al:A new radioimmunoassay for human chorionic gonadotropin using monoclonal antibody. Endocrinol Jap 33:691-700, 1986.

• 4) Suzuki N, Konishi E, Kondo K, et al:A highly sensitive colorimetric sandwich-enzyme immunoassay for human chorionic gonadotropin using specific antibodies against the carboxy-terminal portion of the beta-subunit. Clinica Chimica Acta 150:247-253, 1985.

• 5) Endo T, Nishimura R, Kawano T, et al:Structural differences found in the asparagine-linked sugar chains of human chorionic gonadotropins purified from the urine of patients with invasive mole and choriocarcinoma. Cancer Res 47:5242-5245, 1987.
  pubmed

• 6) Mano H, Furuhashi Y, Hattori S, et al:Radioimmunodetection of human choriocarcinoma xenografts by monoclonal antibody to placental alkaline phosphatase. Jpn J Cancer Res 77:160-167, 1986.
  pubmed

• 7) Hattori S, Furuhashi Y, Goto S, et al:Specific effect of methotrexate bound to the antibodies against hCG and placental alkaline phosphatase to the cultured human choriocarcinoma cells. Acta Obst Gynaec Jpn 35:33-40, 1983.

• 8) Mano H, Hattori S, Furuhashi Y, et al:Specific in vitro effects of methotrexate entrapped into liposomes bearing antibody fragments against human chorionic gonadotropin on cell growth of cultured human choriocarcinoma cells. Jpn J Cancer Chemother 11:1775-1780, 1984.

• 9) Okayama Y, Goto S, Chen F, et al:The study of drug sensitivity on three newly-established choriocarcinoma cell lines. Acta Obst Gynaec Jpn 39:17-23, 1987.

• 10) Sugiura M, Goto S, Saito M, et al:Establishment and characterization of three new human gestational choriocarcinoma cell lines. Acta Obstet Gynaec Jpn 40:1447-1457, 1988.

• 11) Goto S, Okayama Y, Chen F, et al:Methotrexate-induced resistance to dactiomycin in choriocarcinoma. Cancer 62:873-877, 1988.

第12章 絨毛癌の系統的治療法と治療成績

P.174 掲載の参考文献

• 1) Li MC, Hertz R, Spencer DB:Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med 93:361-366, 1956.
  pubmed

• 2) Ross GT, Stolbach LL, Hertz R:Actinomycin D in the treatment of methotrexate resistant trophoblastic disease in women. Cancer Res 22:1015-1017, 1962.
  pubmed

• 3) Tomoda Y, Arii Y, Kaseki S, et al:Surgical indications for resection in pulmonary metastasis of choriocarcinoma. Cancer 46:2723-2730, 1980.
  pubmed

• 4) Ishizuka T, Tomoda Y, Kaseki S, et al:Intracranial metastasis of choriocarcinoma-A Clinicopathologic Study. Cancer 52:1896-1903, 1983.
  pubmed

• 5) Tomoda Y, Kaseki S, Goto S, et al:Approach for attaining complete cure of trophoblastic disease. Trophoblastic Disease 111-120, 1986.

• 6) Newlands ES, Bagshawe KD:Anti-tumor activity of the epipodophyllin derivative VP16-213 in gestational choriocarcinoma. Europ J Cancer 16:401-405, 1980.

• 7) TanakaT, GotoS, Tomoda Y:Study on HLA in patients with trophoblastic neoplasms. J Nagoya Med Assoc 108:10-16, 1985 (in Japanese).

• 8) 細川 勉, 伊藤治英:絨毛上皮腫の期別分類と予後. 産と婦 39:1106, 1972.
  Medical*Online

• 9) 鈴木寿雄, 可世木成明, 有井吉太郎ほか:絨毛癌の予後因子の分析. 日産婦誌 31:2220-2228, 1979.

• 10) Pettersson F:Staging rules for gestational trophoblastic tumors and fallopian tube cancer. Acta Obstet Gynecol Scand 71:224-225, 1992.
  pubmed

• 11) 絨毛性疾患分類に関する日本産科婦人科学会・日本病理学会合同委員会:日本産科婦人科学会・日本病理学会・絨毛性疾患分類・絨毛性疾患の定義・分類・診断基準. 日産婦誌 34:1806-1814, 1982.

• 12) Bagshawe KD:Risk and prognostic factor in trophoblastic neoplasia. Cancer 38:1373-1385, 1976.
  pubmed

• 13) Suzuki I, Goto S, Yamada A, et al:Pregnancy after chemotherapy for Trophoblastic Disease and Psychosomatic Development in the Progeny. Asia Oceania J Obstet Gynecol 19 (4):407-415, 1993.

• 14) Goto S, Okayama Y, Chen F, et al:Methotrexate-induced resistance to dactiomycin in choriocarcinoma. Cancer 62:873-877, 1988.

• 15) Mano H, Furuhashi Y, Hattori S, et al:Radioimmunodetection of human choriocarcinoma xenografts by monoclinal antibody to placental alkaline phosphatase.Jpn J Cancer Res 77:160-167, 1986.

• 16) Hattori S, Furuhashi Y, Goto S, et al:Specific effect of methotrexate bound to the antibodies against hCG and placental alkaline phosphatase to the cultured human choriocarcinoma cells. Acta Obst Gynaec Jpn 35:33-40, 1983.

第13章 絨毛性疾患治療におけるQOL 妊孕能温存

P.185 掲載の参考文献

• 1) Hertz R, Ross GT, Lipsett MB:Primary chemotherapy of nonmetastasic trophoblastic disease in women. Am J Obstet Gynecol 86:808-814, 1963.

• 2) Kaseki S:Primary chemotherapy of trophoblastic neoplasia-Experience with 123 cases. Acta Obstet Gynecol 26:1069-1076, 1974.

• 3) 友田 豊, 後藤節子, 鈴木孝信ほか:絨毛癌と妊孕能温存. 産婦実際 43(5):679-682, 1994.

• 4) Report by the Registration Committee for Trophoblastic Disease. Acta Obstet Gynecol Japon 39:871-880, 1987.

• 5) Hirokawa K, Tomoda Y, Kaseki S, et al:Recurrence of invasive moles and choriocarcinomas. Asia Oceania J Obstet Gynecol 12:11-20, 1986.

• 6) Suzuki I, Goto S, Yamada A, et al:Pregnancy after chemotherapy for Trophoblastic Disease and Psychosomatic Development in the Progeny. Asia Oceania J Obstet Gynecol 19(4):407-415, 1993.

• 7) 日本母性保護医協会:平成元年度 外表奇形等統計調査結果, 1990.

• 8) 津守 真, 稲毛教子:乳幼児精神神経発達診断法0歳〜3歳まで. 大日本図書, 1981.

• 9) 津守 真, 稲毛教子:乳幼児精神神経発達診断法3歳〜7歳まで. 大日本図書, 1979.